Status:
COMPLETED
Study of Treatment for Adolescents With Bulimia Nervosa
Lead Sponsor:
Stanford University
Collaborating Sponsors:
University of Chicago
Conditions:
Bulimia
Eligibility:
All Genders
12-18 years
Phase:
NA
Brief Summary
In the face of scant literature on the subject, the investigators aim to more clearly identify effective treatments for adolescent bulimia nervosa (BN) through a treatment study comparing two current ...
Detailed Description
BN is a serious disorder that is characterized by extreme concerns about body weight and shape, dieting, and the disinhibited eating behaviors of binging and purging. There are no published randomized...
Eligibility Criteria
Inclusion
- Participants will be adolescents living with at least one of their parents and between the ages of 12 and 18 years of age with a DSM IV diagnosis of BN or partial BN (binge eating and purging at least one time per week over a six month period).
- Males meeting inclusion criteria will also be entered into the study. They must have age-adjusted BMI greater than 17.5, or ideal body weight (IBW) \> 85%.
- Family, for the purposes of this study, includes members of the subject's household, including at least one parent or adult guardian. Single parent families, divorced families, step-parents, and other types of families will be allowed to enter the study.
Exclusion
- psychotic illness or other mental illness requiring hospitalization; bipolar I disorder, depression with active suicidal thoughts and behavior;
- associated physical illness that necessitates hospitalization;
- current dependence on drugs or alcohol;
- current diagnosis of anorexia nervosa or weight less that 85% IBW;
- physical conditions (e.g. diabetes mellitus, pregnancy) known to influence eating or weight;
- currently taking medication for co-morbid conditions for less than 2-months;
- currently taking medications that may induce weight loss, e.g., appetite suppressants such as sibutramine, phentermine, and xenical, unless the participant is willing to withdraw from such medications;
- currently taking medications for symptoms of BN and unwilling to discontinue these prior to initiating treatment in the study
- previous CBT or FBT treatment for BN
- married subjects
- emancipated minors
- family members will be excluded from engaging in treatment for the following reasons:
- Current or history of sexual or physical abuse of the patient by family members. Perpetrators of the abuse will be excluded from treatment. Should sexual or physical abuse by a family member occur during the course of treatment, perpetrators will be excluded from ongoing treatment.
- Substance dependence, psychosis, or severe medical illness that would limit full participation in therapy, or that might put the family member at risk for worsening of their condition during treatment. The decision whether or not to allow these individuals to continue to participate in treatment will be made by the therapist in consultation with the treatment supervisor.
Key Trial Info
Start Date :
January 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2014
Estimated Enrollment :
130 Patients enrolled
Trial Details
Trial ID
NCT00879151
Start Date
January 1 2009
End Date
September 1 2014
Last Update
May 25 2015
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford University School of Medicine
Stanford, California, United States, 94305
2
University of Chicago
Chicago, Illinois, United States, 60637